Correlation Between Dice Molecules and Cullinan Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dice Molecules and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dice Molecules and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dice Molecules Holdings and Cullinan Oncology LLC, you can compare the effects of market volatilities on Dice Molecules and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dice Molecules with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dice Molecules and Cullinan Oncology.

Diversification Opportunities for Dice Molecules and Cullinan Oncology

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Dice and Cullinan is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Dice Molecules Holdings and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Dice Molecules is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dice Molecules Holdings are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Dice Molecules i.e., Dice Molecules and Cullinan Oncology go up and down completely randomly.

Pair Corralation between Dice Molecules and Cullinan Oncology

If you would invest  4,755  in Dice Molecules Holdings on March 10, 2024 and sell it today you would earn a total of  0.00  from holding Dice Molecules Holdings or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy4.76%
ValuesDaily Returns

Dice Molecules Holdings  vs.  Cullinan Oncology LLC

 Performance 
       Timeline  
Dice Molecules Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dice Molecules Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Dice Molecules is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Cullinan Oncology LLC 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cullinan Oncology LLC are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent technical and fundamental indicators, Cullinan Oncology displayed solid returns over the last few months and may actually be approaching a breakup point.

Dice Molecules and Cullinan Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dice Molecules and Cullinan Oncology

The main advantage of trading using opposite Dice Molecules and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dice Molecules position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.
The idea behind Dice Molecules Holdings and Cullinan Oncology LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Transaction History
View history of all your transactions and understand their impact on performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance